77P A new prognostic index for patients with advanced BTC treated with cisplatin, gemcitabine and durvalumabM. Persano, A. Casadei Gardini, J.W. Kim et al.|Immuno-Oncology Technology|2024Cited by 0
106P Impact of molecular alterations in advanced biliary tract cancer (BTC) patients (pts) treated with cisplatin, gemcitabine, durvalumab (CGD): A large global studyF. Lo Prinzi, A. Casadei Gardini, M. Rimini et al.|ESMO Open|2025Cited by 0
104eP A new prognostic index for patients with advanced biliary tract cancer treated with cisplatin, gemcitabine and durvalumabM. Persano, A. Casadei Gardini, M. Rimini et al.|Annals of Oncology|2025Cited by 0